Drug Type Live biotherapeutic products |
Synonyms Paracoccus aminovorans, BM 109, BM109 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
RegulationOrphan Drug (United States) |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Preclinical | South Korea | 01 May 2025 | |
Chronic Kidney Diseases | Preclinical | South Korea | 01 May 2025 | |
Trimethylaminuria | Preclinical | United States | 01 May 2025 | |
Trimethylaminuria | Preclinical | South Korea | 01 May 2025 |